Novel PET Tracer Developed for Imaging Prostate Tumors
By MedImaging International staff writers Posted on 14 Aug 2017 |
Image: A and B show trans-axial 11C-sarcosine hybrid PET/CT images of an adenocarcinoma. Image C shows a separately obtained T2-weighted MR sequence, and Image D shows the resulting PET/MRI registration (Photo courtesy of M. Piert et al., University of Michigan).
A new PET tracer, called Carbon-11 labeled sarcosine (11C-sarcosine) has been used for the first time to image prostate cancer in a human being.
According to the researchers the tracer could also be used to monitor targeted treatment of other cancers in the future.
The researchers from the Division of Nuclear Medicine at the University of Michigan (Ann Arbor, MI, USA) compared the effectiveness of the new 11C-sarcosine tracer with an existing widely-used tracer called 11C-choline in two mouse models, and also carried out the first PET/CT (Computed Tomography) scan with 11C-sarcosine for imaging a human prostate cancer patient. The results of the study were published online in the August 1, 2017, issue of the Journal of Nuclear Medicine.
Sarcosine is partly responsible for the aggressiveness and progression of prostate cancer and enters cells via Proton-coupled Amino acid Transporters (PAT).
The results of the study showed that in preclinical models 11C-sarcosine could produce high-contrast images of a human prostate cancer, and that 11C-sarcosine PET tumor-to-background ratios were significantly higher than those for 11C-choline. The researchers concluded that 11C-sarcosine has potential benefits over 11C-choline, and is a viable prostate cancer imaging tracer.
Professor of radiology at the University of Michigan Division of Nuclear Medicine, Morand Piert, MD, said, "Given the link between 11C-sarcosine cell uptake and PAT transport, the study provides first evidence that PAT expression can be elevated in prostate cancer. To our knowledge, this is the first radiotracer to interrogate the activity of PATs, which play a role as multi-purpose carriers with distinct roles in different cells. In the brain, these transporters are involved in the neuronal amino acid transport. In the intestinal tract, certain PATs play a role as nutrient and drug transporter."
Related Links:
University of Michigan
According to the researchers the tracer could also be used to monitor targeted treatment of other cancers in the future.
The researchers from the Division of Nuclear Medicine at the University of Michigan (Ann Arbor, MI, USA) compared the effectiveness of the new 11C-sarcosine tracer with an existing widely-used tracer called 11C-choline in two mouse models, and also carried out the first PET/CT (Computed Tomography) scan with 11C-sarcosine for imaging a human prostate cancer patient. The results of the study were published online in the August 1, 2017, issue of the Journal of Nuclear Medicine.
Sarcosine is partly responsible for the aggressiveness and progression of prostate cancer and enters cells via Proton-coupled Amino acid Transporters (PAT).
The results of the study showed that in preclinical models 11C-sarcosine could produce high-contrast images of a human prostate cancer, and that 11C-sarcosine PET tumor-to-background ratios were significantly higher than those for 11C-choline. The researchers concluded that 11C-sarcosine has potential benefits over 11C-choline, and is a viable prostate cancer imaging tracer.
Professor of radiology at the University of Michigan Division of Nuclear Medicine, Morand Piert, MD, said, "Given the link between 11C-sarcosine cell uptake and PAT transport, the study provides first evidence that PAT expression can be elevated in prostate cancer. To our knowledge, this is the first radiotracer to interrogate the activity of PATs, which play a role as multi-purpose carriers with distinct roles in different cells. In the brain, these transporters are involved in the neuronal amino acid transport. In the intestinal tract, certain PATs play a role as nutrient and drug transporter."
Related Links:
University of Michigan
Latest Radiography News
- Novel Breast Imaging System Proves As Effective As Mammography
- AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
- AI Could Boost Clinical Adoption of Chest DDR
- 3D Mammography Almost Halves Breast Cancer Incidence between Two Screening Tests
- AI Model Predicts 5-Year Breast Cancer Risk from Mammograms
- Deep Learning Framework Detects Fractures in X-Ray Images With 99% Accuracy
- Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT
- Chest X-Ray AI Solution Automatically Identifies, Categorizes and Highlights Suspicious Areas
- AI Diagnoses Wrist Fractures As Well As Radiologists
- Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%
- 3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery
- Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts
- AI Solution Provides Radiologists with 'Second Pair' Of Eyes to Detect Breast Cancers
- AI Helps General Radiologists Achieve Specialist-Level Performance in Interpreting Mammograms
- Novel Imaging Technique Could Transform Breast Cancer Detection
- Computer Program Combines AI and Heat-Imaging Technology for Early Breast Cancer Detection